Elanco Animal Health Incorporated (ELAN) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 
Elanco Animal Health Incorporated  (NYSE: ELAN)
 

Elanco Animal Health Incorporated Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Elanco Animal Health Incorporated's Inventory turnover ratio has remained unchanged compare to previous quarter at 1.29 in the second quarter 2026Average processing period, for Elanco Animal Health Incorporated's inventories remained unchanged at 283 days, in the Jun 30 2026 quarter.

Within Healthcare sector 285 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the II Quarter 2026, to 1783, from total ranking in the first quarter 2026 at 1950.

ELAN Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Elanco Animal Health Incorporated Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ELAN Inventory Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Inventory Growth 5.93 % 7.85 % 10.36 % 4.66 % 3.66 %
Y / Y Cost of Sales Growth 7.95 % 15.13 % 10.78 % 7.72 % 6.67 %
Inventory Turnover Ratio (TTM) 1.29 1.29 1.27 1.26 1.26
ELAN's Total Ranking # 1783 # 1950 # 1838 # 1844 # 1853
Average inventory processing period 282 284 288 289 291
Seq. Inventory Growth 3.03 % -1.15 % 1.7 % 2.28 % 4.9 %
Seq. Cost of Sales Growth -2.73 % 5.59 % 4.72 % 0.38 % 3.73 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 79
Healthcare Sector # 286
Overall Market # 1783

Inventory Turnover Ratio Statistics
High Average Low
1.52 1.33 1.14
(Sep 30 2021)   (Sep 30 2023)



ELAN Company Profile >> Back to ELAN Efficiency Comparisons >> Compare ELAN Inventory Turnover Ratio to its Competitors

Financial Statements
Elanco Animal Health Incorporated's Inventories $ 1,769 Millions Visit ELAN's Balance sheet
Elanco Animal Health Incorporated's Cost of Revenues TTM $ 2,241 Millions Visit ELAN's Income Statement
What are ELAN's Sales? Visit ELAN's Sales by Segment

Other Inventory Turnover Ratios
Elanco Animal Health Incorporated's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
ELAN's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for ELAN's Competitors
Inventory Turnover Ratio for ELAN's Suppliers
Inventory Turnover Ratio for ELAN's Customers

You may also want to know
ELAN's Sales Growth Rates ELAN's Pe Price to earnings ratio ELAN's Receivables Turnover Ratio ELAN's Stock Quote
ELAN's Net Income Growth Rates ELAN's Ps Price to Sales ratio ELAN's Sales per Employee ELAN's Asset Turnover Ratio
ELAN's Net Margin ELAN's Pb Price to Book ratio ELAN's Financial Strength Ratios ELAN's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Lifeward ltd   3.47 $ 13.976  Millions$ 4  Millions
Tandem Diabetes Care Inc   3.46 $ 456.703  Millions$ 132  Millions
Baxter International Inc   3.46 $ 8,020.000  Millions$ 2,317  Millions
Mirum Pharmaceuticals Inc   3.40 $ 85.221  Millions$ 25  Millions
Zai Lab Limited  3.39 $ 195.542  Millions$ 58  Millions
Bellevue Life Sciences Acquisition Corp  3.38 $ 1.215  Millions$ 0  Millions
Evolus Inc   3.37 $ 105.904  Millions$ 31  Millions
Gilead Sciences Inc   3.35 $ 6,217.000  Millions$ 1,857  Millions
10x Genomics Inc   3.29 $ 184.539  Millions$ 56  Millions
Exelixis Inc   3.28 $ 85.665  Millions$ 26  Millions
Biofrontera Inc   3.28 $ 6.622  Millions$ 2  Millions
Maravai Lifesciences Holdings Inc   3.22 $ 135.038  Millions$ 42  Millions
Solventum Corporation  3.22 $ 3,421.000  Millions$ 1,061  Millions
Agilent Technologies inc   3.20 $ 3,404.000  Millions$ 1,064  Millions
Mettler toledo International Inc   3.18 $ 1,277.460  Millions$ 401  Millions
Bionexus Gene Lab Corp   3.15 $ 2.362  Millions$ 1  Millions
Zevra Therapeutics Inc   3.14 $ 6.180  Millions$ 2  Millions
Prestige Consumer Healthcare Inc   3.13 $ 513.522  Millions$ 164  Millions
Eton Pharmaceuticals Inc   3.11 $ 44.176  Millions$ 14  Millions
Becton Dickinson And Company  3.09 $ 11,161.000  Millions$ 3,615  Millions
Mimedx Group Inc   3.07 $ 75.981  Millions$ 25  Millions
Revvity Inc  2.98 $ 1,136.473  Millions$ 381  Millions
Amneal Pharmaceuticals Inc   2.98 $ 1,891.689  Millions$ 635  Millions
Akebia Therapeutics Inc   2.96 $ 44.632  Millions$ 15  Millions
Msa Safety Inc  2.92 $ 1,021.036  Millions$ 350  Millions
Ligand Pharmaceuticals Incorporated  2.91 $ 32.387  Millions$ 11  Millions
Logicmark Inc  2.83 $ 3.881  Millions$ 1  Millions
Iovance Biotherapeutics inc   2.81 $ 152.872  Millions$ 54  Millions
Livanova Plc  2.79 $ 468.065  Millions$ 168  Millions
Merck and Co Inc   2.79 $ 17,996.000  Millions$ 6,447  Millions

Date modified: 2026-09-08T13:46:10+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.